title: Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity.
abstract: This series of reports describe the development of orally active, highly potent, specific antagonists of the peptidoleukotrienes containing a (2-quinolinylmethoxy)phenyl moiety. The compounds reported in this paper contain an additional phenyl ring, which has significantly improved the receptor affinity. The effect of changes in the linkage between the two phenyl rings as well as the orientation of the acidic functional group on biological activity are discussed. Many of these compounds have high affinity to the sulfidopeptide leukotriene D4 receptors with Ki values ranging between 2 and 20 nM and are orally active. Compound 27 [RG 12525, 5-[[2-[[4-(2-quinolinylmethoxy)phenoxy]- methyl]phenyl]methyl]-1H-tetrazole] represents the best combination of in vitro and in vivo biological activity in this series and has been selected for further evaluation in clinical studies of asthma.
authors.affiliation: Rorer Central Research, Horsham, Pennsylvania 19044.
authors.forename: F C
authors.initials: FC
authors.lastname: Huang
authors.forename: R A
authors.initials: RA
authors.lastname: Galemmo
authors.forename: W H
authors.initials: WH
authors.lastname: Johnson
authors.forename: G B
authors.initials: GB
authors.lastname: Poli
authors.forename: M M
authors.initials: MM
authors.lastname: Morrissette
authors.forename: J J
authors.initials: JJ
authors.lastname: Mencel
authors.forename: J D
authors.initials: JD
authors.lastname: Warus
authors.forename: H F
authors.initials: HF
authors.lastname: Campbell
authors.forename: G W
authors.initials: GW
authors.lastname: Nuss
authors.forename: G W
authors.initials: GW
authors.lastname: Carnathan
mesh_terms: D000818:Animals; D001393:Azoles / Q000138:chemical synthesis*; D001993:Bronchodilator Agents / Q000138:chemical synthesis*; D055598:Chemical Phenomena; D002621:Chemistry; D006168:Guinea Pigs; D020024:Leukotriene Antagonists; D008168:Lung / Q000187:drug effects; D010647:Phenyl Ethers / Q000138:chemical synthesis* / Q000494:pharmacology; D011804:Quinolines / Q000138:chemical synthesis* / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000187:drug effects* / Q000378:metabolism; D018102:Receptors, Leukotriene B4; D013189:SRS-A / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D013777:Tetrazoles / Q000138:chemical synthesis* / Q000494:pharmacology
chemical_list: D001393:Azoles; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists; D010647:Phenyl Ethers; D011804:Quinolines; D011971:Receptors, Immunologic; D018102:Receptors, Leukotriene B4; D013189:SRS-A; D013777:Tetrazoles; C059101:RG 12525